- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 28, 2025 | 272.79M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $42.4K |
| Capex | Q1 2024 · Mar 31, 2023 | $25.73K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$1.19M |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$948.13K |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $40.85M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $39.97M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | −$7.67M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$3.62M |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $31.41M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $31.8M |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $77.91M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $77.41M |
| Current Assets restated | Q1 2024 · Mar 31, 2024 | $16.9M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $19.65M |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $79.69M |
| Total Assets restated | Q1 2024 · Dec 31, 2023 | $83.6M |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $3.82M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $3.05M |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$26.62M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$1.63M |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$2.26M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$980.66K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2024 | $4.57M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $4.79M |